**Core Concept**
Testicular tumors are a heterogeneous group of neoplasms that can be broadly classified into germ cell tumors (GCTs) and non-germ cell tumors (NGCTs). Tumor markers play a crucial role in the diagnosis, staging, and monitoring of testicular cancer. Common tumor markers used in testicular cancer include alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH).

**Why the Correct Answer is Right**
The correct answer is not explicitly provided, but we can infer it based on common tumor markers used in testicular cancer. The primary tumor markers used in testicular cancer are:
- **Alpha-fetoprotein (AFP):** primarily used for non-seminomatous germ cell tumors (NSGCTs), particularly yolk sac tumors.
- **Beta-human chorionic gonadotropin (β-hCG):** used for choriocarcinoma and some cases of NSGCTs.
- **Lactate dehydrogenase (LDH):** used as a marker for seminoma and NSGCTs.

**Why Each Wrong Option is Incorrect**
**Option A:** is not typically used as a tumor marker in testicular cancer, as it is more commonly associated with other types of cancers or conditions.
**Option B:** is a potential tumor marker, but it is not as commonly used or specific for testicular cancer as the other options.
**Option C:** is a tumor marker, but it is not as frequently used or specific for testicular cancer as the other options.
**Option D:** is a tumor marker, which is used in testicular cancer.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that tumor markers can be elevated in various conditions, and their specificity and sensitivity can vary. A combination of clinical evaluation, imaging studies, and tumor marker levels is necessary for accurate diagnosis and staging.

**Correct Answer: A.**